Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 3Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3

Conditions

Brain Neoplasms 1050Glioblastoma 920Glioma 603Central Nervous System Neoplasms 436Astrocytoma 396Gliosarcoma 339Neuroblastoma 325Oligodendroglioma 255Neoplasms 181Medulloblastoma 165Breast Neoplasms 154Sarcoma 114Recurrence 108Ependymoma 105Neoplasm Metastasis 95Meningioma 91Melanoma 88Lymphoma 87Carcinoma, Non-Small-Cell Lung 87Lung Neoplasms 82Precursor Cell Lymphoblastic Leukemia-Lymphoma 79Neurofibromatosis 1 79Wilms Tumor 75Osteosarcoma 69Head and Neck Neoplasms 69Ovarian Neoplasms 68Testicular Neoplasms 67Lymphoma, Non-Hodgkin 67Burkitt Lymphoma 66Familial ependymoma 63

Interventions

Genetic Testing 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Dyslexia × CNS × Clear all
NCT00624234 2025-07-08

Neurobiology and Treatment of Reading Disability in NF-1

Vanderbilt University

Phase NA Completed
184 enrolled 10 charts
CNS

Dyslexia, Learning Disabilities, Neurofibromatosis 1

NCT02422732 2015-08-19

Functional Imaging and Reading Deficit in Children With NF1

University Hospital, Toulouse

Phase NA Completed
25 enrolled
CNS

Dyslexia, Neurofibromatosis 1

NCT02397967 2015-03-26

Reading Disability in Children With NF1

University Hospital, Toulouse

Phase NA Completed
181 enrolled
CNS

Dyslexia, Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡